Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

The impact of polypharmacy on toxicity from chemotherapy in elderly patients: Focus on cytochrome P-450 inhibition and protein binding effects

(2017) M. Popa et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy dose adjustment after severe toxicity in older cancer patients

(2017) C. A. O’Leary et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk and Timing of Neutropenic Events in Adult Cancer Patients Receiving Chemotherapy: The Results of a Prospective Nationwide Study of Oncology Practice

(2017) Jeffrey Crawford et al.   Journal of the National Comprehensive Cancer Network

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy

(2010) Bjørn H. Grønberg et al.   EUROPEAN JOURNAL OF CANCER

P106 Comparison of older patients receiving chemotherapy in the community versus an academic cancer center

(2009) M. Extermann et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer

(2008) Marjorie Zauderer et al.   BREAST CANCER RESEARCH AND TREATMENT